Lung diseases are almost invariably heterogeneous and progressive, making it imperative to capture temporally and spatially explicit information to understand the disease initiation and progression. Imaging the lung with MRI-particularly in the preclinical setting-has historically been challenging because of relatively low lung tissue density, rapid cardiac and respiratory motion, and rapid transverse (T